Cristin Rothfuss - EVP, General Counsel at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, General Counsel
Stock Symbol
SRPT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cristin Rothfuss since 12/4/2023

Holdings reported by Cristin Rothfuss for Sarepta Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 13.8K $1.42M $102.89 Nov 26, 2024 Direct
Stock Option (right to buy) 4K Nov 26, 2024 Direct Common Stock

Transactions reported by Cristin Rothfuss for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.